Awakn Life Sciences (TSE:AWKN) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Awakn Life Sciences Corp., a clinical-stage biotechnology company, has announced the successful closure of a second tranche in its private placement, raising additional funds of $394,285 through the issuance of 857,142 units. This capital boost is aimed at enhancing the company’s general working capital while advancing its focus on developing treatments for Alcohol Use Disorder. Each unit in the placement includes one common share and a purchase warrant, which potentially increases investment value for the holders.
For further insights into TSE:AWKN stock, check out TipRanks’ Stock Analysis page.